Business Experimental Alzheimer’s Drug Shows Promise by Targeting Tau Protein July 14, 2026 An experimental drug shows promise in slowing early Alzheimer’s disease through a markedly different mechanism than current treatments. Biogen’s diranersen lowers levels of the brain protein tau, researchers reported Tuesday…